In Person Seminar: Nanocardiology: A Microscopy-Driven Approach to Cardiac Biology and Physiology
Rengasayee Veeraraghavan, Ph.D.
Assistant Professor
Department of Biomedical Engineering
The Ohio State University
In Person Seminar: Nanocardiology: A Microscopy-Driven Approach to Cardiac Biology and Physiology
Date: March 31, 2022
Time: 11:00 a.m. - 12:00 p.m.
Location: This lecture is anticipated to be presented in-person in Room G101A-B, 4 Riverside Circle, at the Fralin Biomedical Research Institute in Roanoke, Virginia, and will also be hosted virtually.
Seating for this event is limited. Masks are not required but are encouraged for in person attendees due to COVID-19 safety concerns.
Virtual Access: Watch this lecture live via Zoom, or on our Live Webcast page.
About this Seminar
A growing body of evidence indicates that cardiac biology and physiology at cellular through organ scales are governed by the action of proteins organized within nanodomains with specialized ultrastructural properties. Importantly, multiple phenomena have been identified, such as ephaptic coupling and excitation-contraction coupling, whose function in health and dysfunction in disease cannot be predicted without accounting for the makeup and behavior of nanodomains. Thus, Dr. Veeraraghavan's laboratory’s investigative approach is grounded in high resolution structural and functional imaging, which is complemented by nanoelectrophysiology (Prez Radwański), functional imaging (Sándor Györke) and computational modeling (Seth Weinberg). Dr. Veeraraghavan will present results from three ongoing projects to illustrate how this multi-pronged approach is enabling us to take on biological and physiological questions ranging from basic science to translational.
1) The nuts and bolts of cardiac impulse propagation: Cardiac myocytes are electrically coupled via highly specialized and heterogeneous structures called intercalated disks. Using his lab's novel indirect correlative light and electron microscopy (iCLEM) approach, Dr. Veeraraghavan's research team is compiling the first-ever quantitative picture of intercalated disks in healthy, experimentally perturbed and diseased hearts including ultrastructural and molecular organization properties from nano- through micro-scales. These data are incorporated into computational models of cardiac impulse propagation to predict structure-function relationships, which are then verified through functional experiments (optical mapping). Using this approach, the lab is uncovering hitherto unappreciated aspects of intercalated disk organization and their roles in modulating cardiac impulse propagation via ephaptic coupling, self-attenuation and other nanoscale mechanisms.
2) Multiscale arrhythmia mechanisms in calmodulinopathy: The D96V mutation in calmodulin is associated with severe APD prolongation, consequent long QT, and triggered arrhythmias. Although this mutation was shown to pathologically enhance the L-type Ca2+ current, that effect was insufficient to explain the observed arrhythmogenic impacts. By combining structural (STORM single molecule localization microscopy) and functional (scanning ion conductance microscopy-guided ‘smart’ patch clamp) with molecular through in vivo scale approaches, Dr. Veeraraghavan has uncovered how this defect in calmodulin dysregulates NaV1.6 neuronal sodium channel inactivation and structural organization along cardiomyocyte transverse tubules to promote pro-arrhythmic Na+/Ca2+ mishandling. Importantly, the lab is developing and translating novel antiarrhythmic therapies designed to selectively and safely target NaV1.6.
3) Distributed protein synthesis in cardiac myocytes: It has long been thought that membrane proteins in cardiac myocytes must be synthesized in perinuclear rough endoplasmic reticulum before being trafficked to sites of deployment. Using single molecule RNA visualization and spatial image analysis, Dr. Veeraraghavan and his lab have discovered that some membrane proteins (eg. connexin43) follow this canonical scheme whereas others (eg. NaV1.5, RyR2) are synthesized on-demand at sites of deployment from local mRNA pools provided by microtubule trafficking. Furthermore, the lab is now learning that mRNA trafficking and distributed protein synthesis enable concurrent synthesis of key ion channels (NaV1.5, CaV1.2) and their regulators (CaM) within microtranslatomes localized to specific myocyte regions.
You May Also Be Interested In...
-
Home ItemSocial Learning in Borderline Personality Disorder , home
April 4, 2025, 11:00 a.m. | Sarah Fineberg, M.D., Ph.D., Assistant Professor, Department of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemBringing Precision Medicine to Psychiatry , home
April 10, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jordan Smoller, M.D., Sc.D., Massachusetts General Hospital Trustees Endowed Chair in Psychiatric Neuroscience; Professor of Psychiatry, Harvard Medical School; Professor of Epidemiology, T.H. Chan Harvard School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture
-
Home ItemExtracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart , home
April 11, 2025, 11:00 a.m. | Susmita Sahoo, Ph.D., Associate Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemA Human-Centric View of Cerebellar Development , home
April 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemMolecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , home
May 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemA Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , home
May 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke